Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Kuwait.
Campus
Campus

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Expert Group Consensus From The Arabian Peninsula On The Diagnosis Of Late Onset Pompe Disease (LOPD)

Expert Group Consensus From The Arabian Peninsula On The Diagnosis Of Late Onset Pompe Disease (LOPD)

Learn more
Expert Group Consensus From The Arabian Peninsula On The Diagnosis Of Late Onset Pompe Disease for orthopedists

Expert Group Consensus From The Arabian Peninsula On The Diagnosis Of Late Onset Pompe Disease for orthopedists

Learn more
Differential Diagnosis Of Late Onset Pompe Disease (LOPD) and Myotonic Dystrophy Type 1 Through Abdominal Ultrasonography

Differential Diagnosis Of Late Onset Pompe Disease (LOPD) and Myotonic Dystrophy Type 1 Through Abdominal Ultrasonography

Learn more
Diagnostic Algorithm for Gaucher Disease in Pediatric

Diagnostic Algorithm for Gaucher Disease in Pediatric

Learn more
Diagnostic Algorithm for Gaucher Disease in Adult

Diagnostic Algorithm for Gaucher Disease in Adult

Learn more
Bone Monitoring Guidelines in Gaucher Disease Video

Bone Monitoring Guidelines in Gaucher Disease Video

Learn more
No Rebound Effect Post Clopidogrel Withdrawal

No Rebound Effect Post Clopidogrel Withdrawal

Learn more
PCSK9 inhibitors and ACS

PCSK9 inhibitors and ACS

Learn more
Evaluation of lipid management following ACS

Evaluation of lipid management following ACS

Learn more
The InRange Study

The InRange Study

Learn more
T1DM Mini-Series: Edition JUNIOR trial results

T1DM Mini-Series: Edition JUNIOR trial results

Learn more
Clinical practice experience in patients with familial hypercholesterolemia (FH) from the SAFEHEART registry

Clinical practice experience in patients with familial hypercholesterolemia (FH) from the SAFEHEART registry

Proprotein convertase subtilisin/kexin type 9 inhibitors for heterozygous familial hypercholesterolemia: A clinical practice experience from the SAFEHEART registry

Learn more